Birce Lal Yalçın, Özgür Değirmenci, Mehmet Çağdaş Eker
{"title":"Pisa Syndrome with Metronome Pattern: A Rare Case Associated with Aripiprazole Treatment.","authors":"Birce Lal Yalçın, Özgür Değirmenci, Mehmet Çağdaş Eker","doi":"10.29399/npa.29363","DOIUrl":"10.29399/npa.29363","url":null,"abstract":"<p><strong>Introduction: </strong>Pisa syndrome is a drug-induced dystonia characterized by lateral truncal flexion. \"A metronome-like pattern,\" a rare variant characterized by alternating directions of deviation, may offer insights into the pathophysiology of extrapyramidal symptoms. This case report describes a rare case of Pisa syndrome induced by aripiprazole, in which the direction of truncal deviation changed following biperiden administration.</p><p><strong>Case: </strong>We describe a 41-year-old female with rapid-cycling bipolar disorder treated with aripiprazole and clozapine who presented with marked rightward truncal flexion. Given her acute manic state, the anticholinergic agent biperiden was added to manage the dystonia without reducing antipsychotic dosage. Surprisingly, this intervention coincided with a shift of the deviation to the left-a phenomenon consistent with a metronome-like pattern. The condition resolved completely following a reduction in aripiprazole dose.</p><p><strong>Conclusion: </strong>This case may support the view that Pisa syndrome is a dynamic state sensitive to the equilibrium between dopaminergic and cholinergic systems. We hypothesize that the anticholinergic effect of biperiden, combined with aripiprazole's partial agonist activity, precipitated the directional switch. Clinicians should be aware of this \"direction-switching\" phenomenon when managing drug-induced movement disorders in complex polypharmacy regimens.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"567-569"},"PeriodicalIF":1.0,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yağmur Sever Fidan, Sümeyye Yasemin Çallı, Arda Kızılsert, Nazmiye İlayda Dışpınar Usta, Nisa Parlayıcı Koçak, Emrullah Dündar, Merve Bilgin Koçak, Oğuz Karamustafalıoğlu
{"title":"Real-World Outcomes of Long-Acting Injectable Antipsychotic Use in Community Mental Health Centers: A Mirror-Image Study from Türkiye.","authors":"Yağmur Sever Fidan, Sümeyye Yasemin Çallı, Arda Kızılsert, Nazmiye İlayda Dışpınar Usta, Nisa Parlayıcı Koçak, Emrullah Dündar, Merve Bilgin Koçak, Oğuz Karamustafalıoğlu","doi":"10.29399/npa.29454","DOIUrl":"10.29399/npa.29454","url":null,"abstract":"<p><strong>Introduction: </strong>Long-acting injectable antipsychotics (LAIs) are widely recommended to enhance treatment adherence and reduce relapse among individuals with psychotic disorders; however, real-world evidence from community-based services in middle-income countries remains limited. This study examined the clinical characteristics, treatment patterns, and hospitalization outcomes associated with LAI use within Community Mental Health Centers (CMHCs) in Türkiye.</p><p><strong>Methods: </strong>Using a retrospective observational cohort design with a mirror-image analytic approach, we evaluated 365 patients with schizophrenia, schizoaffective disorder, or atypical psychosis. Person-time-adjusted psychiatric hospitalization rates before and after LAI initiation were compared. Predictors of the transition time from diagnosis to LAI initiation were examined using a General Linear Model (GLM) with 1000-sample bootstrap confidence intervals.</p><p><strong>Results: </strong>A total of 315 patients were eligible for mirror-image analysis. Median hospitalization rates decreased from 0.273 to 0.000 admissions per person-year following LAI initiation. Person-time-adjusted cohort-level rates decreased from 0.335 to 0.039 admissions per person-year, representing an 88.5% relative reduction (rate ratio: 0.115). This reduction was statistically significant (Z=-13.664, p <0.001) with a large effect size (r ≈ 0.83). In GLM analysis, older age, a higher number of previous hospitalizations, and high school education were significantly associated with longer delays in LAI initiation. Among LAI formulations, risperidone was associated with significantly later initiation compared with haloperidol (B=7.680, p=0.036). The model explained a substantial proportion of variance in LAI initiation timing (R²=0.521).</p><p><strong>Conclusions: </strong>These findings indicate a substantial reduction in hospitalization burden following LAI initiation in real-world community settings. The results support reconsidering the tendency to reserve LAIs for later stages of treatment and suggest that earlier use within community-based care may deserve greater consideration. Integrating LAIs within structured CMHC frameworks may create a complementary effect that supports continuity of care and may contribute to long-term outcomes.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"578-583"},"PeriodicalIF":1.0,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emel Uysal, Demet Sağlam Aykut, Evrim Özkorumak Karagüzel, Alper Han Çebi, Mücahit Göktaş
{"title":"Neurocognitive Performance and Peripheral microRNA Expression in Schizophrenia and Obsessive-Compulsive Disorder: A Comparative Study.","authors":"Emel Uysal, Demet Sağlam Aykut, Evrim Özkorumak Karagüzel, Alper Han Çebi, Mücahit Göktaş","doi":"10.29399/npa.29364","DOIUrl":"10.29399/npa.29364","url":null,"abstract":"<p><strong>Introduction: </strong>Schizophrenia and obsessive-compulsive disorder (OCD) are two chronic psychiatric disorders associated with partially overlapping cognitive impairments and neurobiological processes. The aim of this study was to comparatively examine neurocognitive performance and the expression levels of selected peripheral microRNAs (miR-134, miR-137, miR-150, miR-502, and miR-1306) in patients with schizophrenia and OCD relative to healthy controls, and to exploratorily assess potential heterogeneity within OCD by considering autogenous and reactive subtypes.</p><p><strong>Methods: </strong>This cross-sectional study included 20 patients with schizophrenia, 20 patients with OCD, and 20 healthy controls matched for age, sex, and years of education. All participants underwent a standardized neurocognitive test battery assessing executive functions, attention, processing speed, and verbal memory. Plasma miRNA levels were measured from peripheral blood samples using quantitative real-time polymerase chain reaction (qRT-PCR). Within the OCD group, autogenous and reactive obsession subtypes were additionally analyzed.</p><p><strong>Results: </strong>Both schizophrenia and OCD groups showed poorer performance than healthy controls in measures of attention, processing speed, and executive functioning. Verbal memory impairment was more widespread in the schizophrenia group, whereas it was more limited in the OCD group. After controlling for depression and anxiety levels as covariates, many neurocognitive differences remained significant. miR-134 levels were lower in the OCD group, while miR-502 levels were lower in both the OCD and schizophrenia groups compared with healthy controls. Exploratory analyses yielded limited findings suggesting a possible association between miR-502 and executive function measures.</p><p><strong>Conclusion: </strong>The findings suggest a more widespread pattern of neurocognitive impairment in schizophrenia, whereas OCD appears to involve a more selective cognitive impairment characterized predominantly by executive dysfunction, with verbal memory difficulties potentially related to executive processes. Alterations in selected miRNA levels may provide exploratory clues regarding shared and distinct peripheral molecular processes, while the potential relationship between miR-502 and executive functioning warrants confirmation in larger and longitudinal studies.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"555-566"},"PeriodicalIF":1.0,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Relationship Between Persecutory Delusion Subtypes, Attributional Bias, Childhood Trauma, and Offense Profiles in Schizophrenia.","authors":"Işık Batuhan Çakmak, Burcu Yatkin Güney, Eda Öztürk, Hatice Çiftci, Bengisu Çatli, Şahin Gürkan, Erol Göka","doi":"10.29399/npa.29399","DOIUrl":"10.29399/npa.29399","url":null,"abstract":"<p><strong>Introduction: </strong>Schizophrenia is associated with an increased risk of offending, likely mediated by multiple clinical and psychosocial factors. Childhood trauma, attributional biases, and persecutory delusions have been implicated in both psychosis and aggression; however, their relationships with verified offense categories remain unclear. This study investigated the associations between childhood trauma, attributional biases, persecutory delusion subtypes, and offense categories in individuals with schizophrenia.</p><p><strong>Methods: </strong>Ninety-six individuals with schizophrenia under court-ordered forensic psychiatric monitoring and with at least one verified criminal offense were included. Participants were in remission and adherent to treatment. The Childhood Trauma Questionnaire - Short Form, Internal, Personal and Situational Attributions Questionnaire-Turkish Form, and Persecution and Deservedness Scale were administered. Delusional subtypes were classified as poor-me (PM), bad-me (BM), unclassified persecutory, or non-persecutory. Offenses were categorized as interpersonal aggression/violence crimes, property/economic crimes, or system-directed/institutional crimes.</p><p><strong>Results: </strong>Offense categories were not associated with persecutory delusion subtypes. However, personalizing bias was significantly higher among individuals convicted of interpersonal aggression and violence than among those convicted of system-directed and institutional crimes (p=0.042). Childhood trauma differed across delusional subtypes, with higher emotional abuse scores in PM and BM groups and higher physical neglect and total trauma scores in the BM group. In multinomial logistic regression analyses, higher personalizing bias independently predicted lower odds of belonging to the property/economic crime group relative to the interpersonal aggression group (OR=0.029, p=0.035).</p><p><strong>Conclusion: </strong>Delusion subtype was not associated with offense category in schizophrenia. In contrast, personalizing bias was associated with offending patterns, while childhood trauma was linked to specific persecutory delusion subtypes. These findings suggest that attributional processes may be more informative than delusional content alone for understanding offending behavior in schizophrenia.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"570-577"},"PeriodicalIF":1.0,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Social Media Use and Emotional Reactivity to Negative Stimuli: An ERP Investigation.","authors":"Ayşe Ece Atalar, Gökçer Eskikurt, Ezgi Ildırım","doi":"10.29399/npa.29281","DOIUrl":"10.29399/npa.29281","url":null,"abstract":"<p><strong>Introduction: </strong>Exposure to violent media has long been associated with reduced emotional reactivity, empathy, and moral sensitivity, which is a phenomenon commonly referred to as emotional desensitization. Although numerous studies have explored this process in video games and films, its neural correlates in social media contexts remain insufficiently examined. This study aimed to examine whether individual differences in social media use are associated with neural responses to negative emotional stimuli.</p><p><strong>Methods: </strong>Fifty-six healthy young adults participated in an electroencephalography (EEG) experiment, during which they passively viewed negative, neutral, and positive images selected from the International Affective Picture System (IAPS). Emotional processing was assessed using two event-related potential (ERP) components: the Early Posterior Negativity (EPN, 200-300 ms) and the Late Positive Potential (LPP, 300-800 ms). Amplitude differences across stimulus categories and brain regions were analyzed using repeated-measures ANOVA.</p><p><strong>Results: </strong>Negative images elicited significantly greater LPP amplitudes compared to neutral and positive images, particularly across central, parietal, and temporal regions, indicating sustained emotional engagement. In contrast, EPN amplitudes did not differ significantly across conditions, suggesting that early attentional mechanisms were not modulated by emotional valence. No group differences were observed between participants with high and low levels of social media use.</p><p><strong>Conclusion: </strong>The findings indicate that typical social media exposure was not associated with reduced neural responsiveness in this sample. Emotional engagement with negative stimuli remains intact, supporting the notion that desensitization is a gradual, context-dependent process influenced by the nature and intensity of digital exposure.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"547-554"},"PeriodicalIF":1.0,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sıla Özkal, Begüm Tahhan, Çağan Kaplan, Yıldırım Adalıoğlu, Aslı Ceren Hınç, Furkan Yazıcı, Yiğit Erdoğan, Ali Saffet Gönül
{"title":"Subcortical Shape Alterations in Schizophrenia: A Single-Site Validation of ENIGMA's Meta-Analytic Findings.","authors":"Sıla Özkal, Begüm Tahhan, Çağan Kaplan, Yıldırım Adalıoğlu, Aslı Ceren Hınç, Furkan Yazıcı, Yiğit Erdoğan, Ali Saffet Gönül","doi":"10.29399/npa.29228","DOIUrl":"10.29399/npa.29228","url":null,"abstract":"<p><strong>Introduction: </strong>Although meta-analysis by combining samples from multiple studies increases the statistical power, differences in study designs, participant characteristics, and outcome measures can create heterogeneity. Therefore, it might be helpful to validate the results of meta-analysis in independent smaller single site samples. This study investigates the shape characteristics of subcortical structures in schizophrenia patients by replicating and extending findings from a large multi-site meta-analysis using a single-site cohort.</p><p><strong>Methods: </strong>Employing the ENIGMA shape analysis protocol, we examined the MRI images of 57 patients and 37 controls using FreeSurfer.</p><p><strong>Results: </strong>Compared with controls, schizophrenia was associated with surface contraction in the left hippocampus, bilateral thalamus, bilateral nucleus accumbens, and right amygdala, alongside surface expansion in the bilateral putamen, left caudate, and bilateral pallidum; the right caudate showed both expansion and contraction. Thickness reductions were observed in the bilateral hippocampus, bilateral thalamus, bilateral accumbens, and right amygdala, while thickening was most evident in the right pallidum; the caudate, putamen, and left pallidum showed bidirectional thickness patterns. Antipsychotic dosage showed no significant effect on shape measures. Notably, our effect sizes surpassed those observed in earlier multi-site work. Larger effect sizes observed in our study could be attributed to the higher sampling variability due to relatively smaller sample size or increased clinical severity among patients from our single center compared to the patient populations in the meta-analysis.</p><p><strong>Conclusions: </strong>Overall, these findings underscore the utility of shape-based analyses for understanding schizophrenia neuroanatomy, emphasize considering the clinical characteristics of the study sample, and highlight the importance of single-site validation-particularly for cohorts not represented in larger consortia that have higher baseline clinical severity.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"535-540"},"PeriodicalIF":1.0,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seda Güneysu, Ahmet Depreli, Mehmet Cengil Aslan, Emre Gürbüz, Mehmet Altınok
{"title":"The Relationship Between Cumulative Risk Burden and Offense Types and Recidivism Among Juvenile Offenders.","authors":"Seda Güneysu, Ahmet Depreli, Mehmet Cengil Aslan, Emre Gürbüz, Mehmet Altınok","doi":"10.29399/npa.29344","DOIUrl":"10.29399/npa.29344","url":null,"abstract":"<p><strong>Introduction: </strong>Juvenile delinquency is often shaped by cumulative and multidimensional risk exposure rather than isolated risk factors. This study aimed to examine the relationship between cumulative risk burden and both offense types and recidivism among juvenile offenders, and to evaluate the discriminative ability of a behavioral risk factor count for identifying recidivism.</p><p><strong>Methods: </strong>This cross-sectional observational study was conducted using retrospective records of 982 justice-involved children evaluated between January 1, 2024, and June 30, 2025. Associations between sociodemographic, familial, and educational variables and recidivism were examined using hierarchical logistic regression analyses. The discriminative performance of a behavioral risk factor count-comprising smoking, alcohol/substance use, self-harm, tattoo presence, and child labor-was assessed using receiver operating characteristic (ROC) analysis.</p><p><strong>Results: </strong>Family criminal history and low educational attainment were strongly associated with recidivism. The behavioral risk factor count demonstrated moderate-to-high discriminative ability in distinguishing children with and without recidivism (area under the curve [AUC]=0.77). Higher risk factor counts were particularly observed among children involved in property-related crimes.</p><p><strong>Conclusion: </strong>The findings indicate that juvenile delinquency is better understood through a cumulative and multidimensional risk framework rather than single risk indicators. The behavioral risk factor count appears to be a pragmatic tool for early risk screening and stratification, rather than a causal predictor.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"541-546"},"PeriodicalIF":1.0,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13742016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hüsna Kaan, Ali Karayağmurlu, Canan Küçükgergin, İlknur Bingül, Nusret Soylu
{"title":"Investigating Serum miRNA Levels in Autistic Children with and without Bipolar Disorder: A Case-Control Study.","authors":"Hüsna Kaan, Ali Karayağmurlu, Canan Küçükgergin, İlknur Bingül, Nusret Soylu","doi":"10.29399/npa.29202","DOIUrl":"10.29399/npa.29202","url":null,"abstract":"<p><strong>Introduction: </strong>The presence of bipolar disorder (BD) in individuals with ASD exacerbates social and cognitive impairments, complicates diagnosis and treatment. The aim of this study was to compare the serum levels of specific miRNAs between children with ASD with and without BD, and to explore their association with BD comorbidity in ASD.</p><p><strong>Method: </strong>A group of 41 pediatric patients with comorbid ASD + BD and a group of 47 pediatric patients with ASD without BD were included in the study. Serum miRNA levels were measured using quantitative real-time polymerase chain reactions, focusing specifically on miRNAs such as miR-132-5p, miR-134-5p, miR-206, and miR-126-5p.</p><p><strong>Results: </strong>The ASD + BD group exhibited significantly greater ASD severity than the ASD without BD group. Serum levels of miR-134-5p, miR-206, and miR-126-5p were all higher in the ASD + BD group than in the ASD without BD group (p=0.038, p=0.023, and p=0.026, respectively), while miR-132-5p levels were not significantly different (p=0.105). Furthermore, miR-134-5p levels were correlated with the frequency of manic episodes in the ASD + BD group (p=0.007).</p><p><strong>Conclusion: </strong>The study findings suggest that miRNAs may be involved in the pathophysiology of comorbid BD in children with ASD and may potentially represent candidate biomarkers for early diagnosis and intervention, thus contributing to improved clinical outcomes in this population. Further research is now needed to validate these findings and to understand the underlying mechanisms.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"502-509"},"PeriodicalIF":1.0,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148714517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Merve Erdal, Aylin Arı, Ahmed Serkan Emekli, Nihan Çarçak Yılmaz, Murat Kürtüncü
{"title":"Clinical Use of Interleukin-6 Blockade in Neuroimmunological Disorders.","authors":"Merve Erdal, Aylin Arı, Ahmed Serkan Emekli, Nihan Çarçak Yılmaz, Murat Kürtüncü","doi":"10.29399/npa.29355","DOIUrl":"10.29399/npa.29355","url":null,"abstract":"<p><p>Interleukin-6 (IL-6) is a multifunctional cytokine that plays a critical role in immune regulation, host defense, and tissue repair. Within the central nervous system (CNS), IL-6 contributes to both neuroprotection and neuroinflammation, depending on the signaling pathway involved; classic signaling, trans-signaling, or trans-presentation. Dysregulation of IL-6, particularly through sustained overexpression, disrupts the blood-brain barrier (BBB) integrity, promotes glial activation, and amplifies chronic inflammation, thereby contributing to the pathophysiology of numerous neurological disorders. This review aims to evaluate the role of IL-6 in neuroinflammatory processes and its clinical implications across a spectrum of neurological diseases. It focuses on the therapeutic potential and safety profile of IL-6 inhibitors, particularly tocilizumab and satralizumab. Key conditions discussed include neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein-associated disease (MOGAD), autoimmune encephalitis (AE), neuro-Behçet's disease (NBD), myasthenia gravis (MG), epilepsy, multiple sclerosis (MS), and Alzheimer's disease (AD). Clinical trials have demonstrated the efficacy of IL-6 receptor blockade in reducing relapse rates in NMOSD, leading to regulatory approvals. Promising off-label results have also been reported in treatment-resistant cases of MOGAD, epilepsy, and autoimmune conditions. However, IL-6 inhibition carries risks such as serious infections and paradoxical inflammatory reactions. Targeting the IL-6 pathway represents a significant advancement in neuroimmunology, offering new therapeutic opportunities for otherwise refractory conditions. Future research should focus on large-scale randomized controlled trials and the development of IL-6 inhibitors capable of crossing the BBB to enhance CNS-specific efficacy. Cost-related accessibility also remains a major challenge for broader clinical application.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"482-494"},"PeriodicalIF":1.0,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148714447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Büşra Teke, Reyhan İlhan, Muhammed Taha Esmeray, Mehmet Kemal Arıkan
{"title":"Potential Epigenetic Mechanisms of High-Frequency rTMS in the Treatment of Major Depression: A Brief Report of Current Evidence.","authors":"Büşra Teke, Reyhan İlhan, Muhammed Taha Esmeray, Mehmet Kemal Arıkan","doi":"10.29399/npa.29345","DOIUrl":"10.29399/npa.29345","url":null,"abstract":"<p><strong>Introduction: </strong>Repetitive Transcranial Magnetic Stimulation (rTMS) is an FDA-approved, non-invasive neuromodulation technique with clinically supported efficacy in the management of treatment-resistant major depressive disorder (TRD). Although the clinical effectiveness of high-frequency rTMS applied to the left dorsolateral prefrontal cortex (DLPFC) is well established, the molecular mechanisms underlying its long-term therapeutic effects remain incompletely understood. The aim of this brief report is to examine the possible epigenetic modifications (DNA methylation, histone modifications, microRNA) associated with the antidepressant effects of rTMS in light of current literature, and to evaluate the dose-response relationship that may affect treatment response within the framework of homeostatic plasticity.</p><p><strong>Methods: </strong>A summary of current literature from the PubMed, Web of Science, and Google Scholar databases is presented using the keywords \"rTMS,\" \"major depression,\" \"epigenetics,\" \"histone modifications,\" \"DNA methylation,\" \"miRNA,\" and \"homeostatic plasticity.\" Clinical and preclinical studies specifically investigating the molecular effects of rTMS on synaptic plasticity were included.</p><p><strong>Results: </strong>The reviewed studies suggest that rTMS may not merely provide transient electrical stimulation but may also operate through an \"epigenetic regulatory\" mechanism capable of permanently altering neuronal gene expression. In preclinical studies, changes in histone acetylation (e.g., regulation of CDK5 and PSD-95) and specific microRNAs (e.g., miR-146a-5p) have been observed to modulate synaptic plasticity. Furthermore, it has been proposed that the dose-response relationship of rTMS is non-linear; excessive stimulation may activate \"homeostatic plasticity\" mechanisms, thereby reducing synaptic sensitivity.</p><p><strong>Discussion: </strong>Current findings indicate that rTMS may exert an antidepressant effect by reorganizing synaptic plasticity through epigenetic modifications. Enhancing treatment efficacy depends on optimizing the dosage by considering homeostatic balances and integrating epigenetic biomarkers capable of predicting treatment response into clinical practice. Future personalized treatment protocols should be designed based on these molecular and neurophysiological insights.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"63 ","pages":"520-525"},"PeriodicalIF":1.0,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13459177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148714511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}